News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
602,885 Results
Type
Article (25619)
Company Profile (167)
Press Release (576843)
Multimedia
Podcasts (107)
Webinars (19)
Section
Business (196643)
Career Advice (1142)
Deals (30692)
Drug Delivery (133)
Drug Development (67742)
Employer Resources (88)
FDA (12633)
Job Trends (11512)
News (287932)
Policy (24405)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (5)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1378)
Accelerated approval (43)
ADA (51)
Adcomms (25)
Allergies (151)
Alliances (40012)
ALS (153)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (464)
Approvals (13161)
Artificial intelligence (558)
ASCO (329)
Autoimmune disease (305)
Automation (41)
Bankruptcy (318)
Belgium (2)
Best Places to Work (8999)
BIO (65)
Biologics (10)
BIOSECURE Act (18)
Biosimilars (194)
BioSpace Insights (81)
Biotechnology (100)
Bladder cancer (184)
Brain cancer (48)
Breast cancer (666)
Cancer (5315)
Cardiovascular disease (448)
Career advice (947)
Career pathing (31)
CAR-T (288)
CDC (43)
CDMO (85)
Celiac Disease (3)
Cell therapy (760)
Cervical cancer (50)
Clinical research (60400)
Collaboration (1774)
Commercialization (7)
Company closure (3)
Compensation (1589)
Complete response letters (72)
COVID-19 (1559)
CRISPR (89)
C-suite (1080)
Cystic fibrosis (121)
Data (7572)
Decentralized trials (2)
Denatured (19)
Depression (144)
Dermatology (100)
Diabetes (569)
Diagnostics (5405)
Digital health (51)
Diversity (8)
Diversity, equity & inclusion (25)
Drug discovery (285)
Drug pricing (198)
Drug shortages (31)
Duchenne muscular dystrophy (246)
Earnings (80928)
Editorial (65)
Employer branding (11)
Employer resources (89)
Events (106172)
Executive appointments (927)
FDA (15985)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (28)
Funding (1347)
Gene editing (186)
Generative AI (52)
Gene therapy (542)
GLP-1 (867)
Government (2630)
Grass and pollen (3)
Guidances (353)
Healthcare (14057)
Hematology (140)
HIV (75)
Huntington's disease (40)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (107)
Immunology and inflammation (271)
Immuno-oncology (102)
Indications (193)
Infectious disease (1858)
Inflammatory bowel disease (174)
Inflation Reduction Act (10)
Influenza (107)
Intellectual property (287)
Interviews (141)
IPO (14301)
IRA (51)
Job creations (2778)
Job search strategy (845)
JPM (40)
Kidney cancer (24)
Labor market (84)
Layoffs (325)
Leadership (33)
Legal (6484)
Licensing (20)
Liver cancer (68)
Longevity (28)
Lung cancer (754)
Lymphoma (413)
Machine learning (41)
Management (36)
Manufacturing (1005)
Marketing (12)
MASH (176)
Medical affairs (2)
Medical device (10356)
Medtech (10534)
Mergers & acquisitions (17564)
Metabolic disorders (1436)
mRNA (144)
Multiple sclerosis (155)
NASH (14)
Netherlands (2)
Neurodegenerative disease (353)
Neuropsychiatric disorders (93)
Neuroscience (2695)
Neurotech (1)
NextGen: Class of 2026 (4700)
Non-profit (2910)
Now hiring (53)
Obesity (677)
Opinion (222)
Ovarian cancer (198)
Pain (257)
Pancreatic cancer (299)
Parkinson's disease (288)
Partnered (25)
Patents (592)
Patient recruitment (629)
Peanut (57)
People (50833)
Pharmaceutical (43)
Pharmacy benefit managers (34)
Phase 1 (18625)
Phase 2 (26567)
Phase 3 (19751)
Pipeline (9491)
Policy (291)
Postmarket research (2241)
Preclinical (8011)
Press Release (40)
Prostate cancer (276)
Psychedelics (36)
Radiopharmaceuticals (294)
Rare diseases (977)
Real estate (4225)
Recruiting (37)
Regulatory (19940)
Reports (42)
Research institute (1294)
Resumes & cover letters (192)
Rett syndrome (42)
RNA editing (19)
RSV (78)
Schizophrenia (175)
Series A (224)
Series B (165)
Service/supplier (7)
Sickle cell disease (109)
Special edition (25)
Spinal muscular atrophy (119)
Sponsored (17)
Startups (2667)
Stomach cancer (13)
Supply chain (110)
Tariffs (98)
The Weekly (86)
Vaccines (731)
Venture capital (107)
Weight loss (451)
Women's health (112)
Worklife (12)
Date
Today (148)
Last 7 days (479)
Last 30 days (1908)
Last 365 days (24648)
2026 (17278)
2025 (24639)
2024 (28664)
2023 (32476)
2022 (42428)
2021 (45510)
2020 (42571)
2019 (33663)
2018 (25551)
2017 (24841)
2016 (24248)
2015 (30174)
2014 (25907)
2013 (21761)
2012 (23997)
2011 (24528)
2010 (23855)
Location
Africa (494)
Alabama (85)
Alaska (4)
Arizona (350)
Arkansas (13)
Asia (28305)
Australia (3695)
California (13363)
Canada (3606)
China (1095)
Colorado (554)
Connecticut (509)
Delaware (366)
Europe (54277)
Florida (2055)
Georgia (431)
Hawaii (3)
Idaho (50)
Illinois (958)
India (100)
Indiana (487)
Iowa (22)
Japan (576)
Kansas (120)
Kentucky (35)
Louisiana (54)
Maine (30)
Maryland (1447)
Massachusetts (9197)
Michigan (347)
Minnesota (652)
Mississippi (5)
Missouri (118)
Montana (31)
Nebraska (17)
Nevada (128)
New Hampshire (67)
New Jersey (3356)
New Mexico (28)
New York (3307)
North Carolina (1579)
North Dakota (7)
Northern California (6762)
Ohio (361)
Oklahoma (19)
Oregon (25)
Pennsylvania (2521)
Puerto Rico (28)
Rhode Island (41)
South America (864)
South Carolina (80)
South Dakota (1)
Southern California (5483)
Tennessee (167)
Texas (2157)
United States (45342)
Utah (400)
Vermont (2)
Virginia (250)
Washington D.C. (61)
Washington State (1060)
West Virginia (2)
Wisconsin (106)
Wyoming (2)
602,885 Results for "mt pharma america inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sumitomo Pharma America Earns 2026-2027 Great Place to Work Certification™
August 6, 2026
·
3 min read
Press Releases
T-MAXIMUM B7-H3-Targeted Allogeneic CAR-T Therapy MT027 Receives FDA Fast Track Designation, Accelerating Global Development for Intracranial Solid Tumors
August 31, 2026
·
4 min read
Press Releases
Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia
July 30, 2026
·
5 min read
Press Releases
Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa
August 12, 2026
·
7 min read
Press Releases
Mitsubishi Tanabe Pharma America is Now Tanabe Pharma America
December 2, 2025
·
2 min read
Drug Development
Mitsubishi Tanabe Pharma America Presents Final Results from the Global, Phase 3b MT-1186-A02 Post-marketing Study of RADICAVA® (edaravone) in ALS
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of final results from the global, multi-center, double-blind, Phase 3b MT-1186-A02 study of oral edaravone in amyotrophic lateral sclerosis (ALS).
June 17, 2024
·
7 min read
Press Releases
Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
April 2, 2026
·
7 min read
Press Releases
Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-muscle Myosin II in Newly Diagnosed Glioblastoma
May 19, 2026
·
2 min read
China
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
When signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.
July 28, 2026
·
7 min read
·
Annalee Armstrong
Press Releases
Sumitomo Pharma America Presents First Clinical Data for SMP-3124LP, an Investigational PEGylated Liposome CHK1 Inhibitor, at ASCO 2026
June 2, 2026
·
6 min read
1 of 60,289
Next
